Renal Business Today

Generics

FDA Approves Generic Ferrlecit

MORRISTOWN, N.J.—The U.S. Food and Drug Administration (FDA) has approved GeneraMedix Inc.’s generic version of sanofi aventis’ iron drug Ferrlecit. ...More
March 31, 2011
Posted in News, Clinical & Pharma, Government & Regulation
Teva, Barr Can't Sell Generic Sensipar

THOUSAND OAKS, Calif.—Teva Pharmaceuticals and Barr Laboratories will not be able to sell generic versions of Amgen’s Sensipar after a U.S. District Court in Delaware granted an injunction last week. ...More
January 10, 2011
Posted in News, Business, Government & Regulation
Doctors Wary of Generic Transplant Drugs

EXTON, Pa.—A large number on nephrologists and surgeons are wary of generic transplant drugs and question their quality in the care of transplant patients, according to survey results released Aug. 26 by BioTrends Research. ...More
August 26, 2010
Posted in News, Clinical & Pharma
Expensive Blood Pressure Meds No Better than Generics

BEIJING—Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from study results presented Aug. 13 at the plenary session of the China Heart Congress and ...More
August 17, 2010
Posted in News, Clinical & Pharma
FDA Approves Generic High Blood Pressure Patch

PITTSBURGH—The U.S. Food and Drug Administration has approved Mylan Inc.’s generic version of a high blood pressure patch, according to a July 19 news release. ...More
July 21, 2010
Posted in News, Government & Regulation
Genzyme Sues Watson Over Generic Renvela Application

MORRISTOWN, N.J.—Watson Pharmaceuticals Inc. said July 12 that it has submitted an application to the U.S. Food and Drug Administration to approve a generic form of Genzyme’s phosphate binder Renvela. ...More
July 13, 2010
Posted in News, Government & Regulation
Generic Renvela Maker Files for FDA Approval

Generic drug makers have been going after phosphate binders for short while now; however, it could reach a fever pitch after Genzyme sued Impax Laboratories on July 1 for trying to create a generic form of Renvela. ...More
July 7, 2010
Posted in Blog, Clinical & Pharma, Government & Regulation
FDA Approves Generic Hypertension Drugs

The U.S. Food and Drug Administration says it has approved the first generic versions of two drugs used for the treatment of hypertension. ...More
April 13, 2010
Posted in News, Clinical & Pharma, Government & Regulation
HAI Drug Market Will Decrease Modestly by 2018

WASHINGTON—Decision Resources, a leading research and advisory firm for pharmaceutical and healthcare issues, finds that, through 2018, the crowded hospital-acquired infections (HAIs) drug market will be constrained by aggressive generic erosion of key brands, intensified ...More
April 7, 2010
Posted in News, Business, Clinical & Pharma, Practice Management
Future Iron Treatments Shaped by New Payment Structures, Products

The choice of what iron product to use will be especially relevant with the bundled payment set to start in 2011. According to an August 2009 BioTrends report, dialysis clinic medical directors foresee the increased use of IV iron to spare the use of ESAs (such as Amgen’s ...More
January 29, 2010
Posted in Articles, Business, Clinical & Pharma, Practice Management

featured links

HOT TOPICS

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Generics

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail